This site is intended for healthcare professionals
News

European Commission approves Reblozyl to treat myelodysplastic syndromes and transfusion-dependent anemia associated with beta thalassemia.- BMS + Acceleron Pharma

Read time: 1 mins
Last updated:29th Jun 2020
Published:27th Jun 2020
Condition: Beta-thalassemia
Type: drug
Register free for full access to medthority.com